AFMD
Price
$0.73
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
12.02M
33 days until earnings call
AUTL
Price
$1.43
Change
+$0.08 (+5.93%)
Updated
Apr 17 closing price
Capitalization
380.56M
13 days until earnings call
Ad is loading...

AFMD vs AUTL

Header iconAFMD vs AUTL Comparison
Open Charts AFMD vs AUTLBanner chart's image
Affimed
Price$0.73
Change-$0.00 (-0.00%)
Volume$15.45K
Capitalization12.02M
Autolus Therapeutics
Price$1.43
Change+$0.08 (+5.93%)
Volume$1.17M
Capitalization380.56M
AFMD vs AUTL Comparison Chart
Loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AFMD vs. AUTL commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMD is a Hold and AUTL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (AFMD: $0.73 vs. AUTL: $1.43)
Brand notoriety: AFMD and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AFMD: 15% vs. AUTL: 78%
Market capitalization -- AFMD: $12.02M vs. AUTL: $380.56M
AFMD [@Biotechnology] is valued at $12.02M. AUTL’s [@Biotechnology] market capitalization is $380.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AFMD’s FA Score shows that 0 FA rating(s) are green whileAUTL’s FA Score has 1 green FA rating(s).

  • AFMD’s FA Score: 0 green, 5 red.
  • AUTL’s FA Score: 1 green, 4 red.
According to our system of comparison, AUTL is a better buy in the long-term than AFMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AFMD’s TA Score shows that 6 TA indicator(s) are bullish while AUTL’s TA Score has 5 bullish TA indicator(s).

  • AFMD’s TA Score: 6 bullish, 2 bearish.
  • AUTL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AFMD is a better buy in the short-term than AUTL.

Price Growth

AFMD (@Biotechnology) experienced а +17.17% price change this week, while AUTL (@Biotechnology) price change was +25.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

AFMD is expected to report earnings on Aug 07, 2025.

AUTL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($381M) has a higher market cap than AFMD($12M). AFMD (-38.361) and AUTL (-39.149) have similar YTD gains . AFMD has higher annual earnings (EBITDA): -65.19M vs. AUTL (-192.51M). AUTL has more cash in the bank: 657M vs. AFMD (24.9M). AFMD has less debt than AUTL: AFMD (12.9M) vs AUTL (52.2M). AUTL has higher revenues than AFMD: AUTL (10.1M) vs AFMD (877K).
AFMDAUTLAFMD / AUTL
Capitalization12M381M3%
EBITDA-65.19M-192.51M34%
Gain YTD-38.361-39.14998%
P/E RatioN/AN/A-
Revenue877K10.1M9%
Total Cash24.9M657M4%
Total Debt12.9M52.2M25%
FUNDAMENTALS RATINGS
AFMD vs AUTL: Fundamental Ratings
AFMD
AUTL
OUTLOOK RATING
1..100
1215
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
9494
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (31) in the Biotechnology industry is somewhat better than the same rating for AFMD (70). This means that AUTL’s stock grew somewhat faster than AFMD’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AFMD (100). This means that AUTL’s stock grew similarly to AFMD’s over the last 12 months.

AUTL's SMR Rating (96) in the Biotechnology industry is in the same range as AFMD (96). This means that AUTL’s stock grew similarly to AFMD’s over the last 12 months.

AUTL's Price Growth Rating (94) in the Biotechnology industry is in the same range as AFMD (94). This means that AUTL’s stock grew similarly to AFMD’s over the last 12 months.

AFMD's P/E Growth Rating (95) in the Biotechnology industry is in the same range as AUTL (100). This means that AFMD’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AFMDAUTL
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 21 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSTX55.47N/A
N/A
Putnam Global Health Care A
GGRCX12.43N/A
N/A
Goldman Sachs Strategic Growth C
PIGFX30.81N/A
N/A
Pioneer Fundamental Growth A
RIVSX15.39N/A
N/A
River Oak Discovery
IHSFX19.46N/A
N/A
Hartford Small Company F

AFMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with BYSI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then BYSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
+1.03%
BYSI - AFMD
40%
Loosely correlated
+3.97%
GPCR - AFMD
40%
Loosely correlated
+17.43%
NTLA - AFMD
37%
Loosely correlated
+5.39%
LRMR - AFMD
35%
Loosely correlated
+3.80%
CRSP - AFMD
34%
Loosely correlated
-0.03%
More

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+5.93%
CRSP - AUTL
43%
Loosely correlated
-0.03%
RCKT - AUTL
40%
Loosely correlated
+2.93%
RGNX - AUTL
40%
Loosely correlated
-3.57%
CABA - AUTL
40%
Loosely correlated
+1.85%
KALV - AUTL
39%
Loosely correlated
+2.17%
More